Complex 2 mitochondrial respiratory chain deficiency

Complex II Mitochondrial Respiratory Chain Deficiency is a rare genetic condition that affects the mitochondrial respiratory chain, specifically the second complex, also known as succinate dehydrogenase (SDH). This condition is part of a group of disorders known as mitochondrial diseases, which are characterized by dysfunctional mitochondria, the organelles responsible for producing energy in cells.

Overview

Mitochondria are known as the powerhouses of the cell, generating most of the cell's supply of adenosine triphosphate (ATP), used as a source of chemical energy. Within the mitochondria, the respiratory chain is a series of complexes (I-IV) that work together to produce ATP through a process called oxidative phosphorylation. Complex II, or succinate dehydrogenase, is unique among the respiratory chain complexes because it is the only one that is entirely encoded by nuclear DNA, rather than mitochondrial DNA. Complex II Mitochondrial Respiratory Chain Deficiency occurs when there are mutations in the genes that encode for the proteins in Complex II, leading to reduced function or complete dysfunction of this complex.

Symptoms

The symptoms of Complex II Mitochondrial Respiratory Chain Deficiency can vary widely among affected individuals, reflecting the diverse roles of mitochondria in different tissues. Common symptoms include muscle weakness, heart problems, breathing difficulties, and developmental delays. More severe cases can lead to Leigh syndrome, a progressive neurological disorder that typically arises in the first year of life.

Genetics

The condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. The genes known to be associated with Complex II deficiency include SDHA, SDHB, SDHC, and SDHD, which encode the four subunits of succinate dehydrogenase.

Diagnosis

Diagnosis of Complex II Mitochondrial Respiratory Chain Deficiency involves a combination of clinical evaluation, biochemical tests to measure the activity of Complex II in muscle or other tissues, and genetic testing to identify mutations in the associated genes.

Treatment

There is no cure for Complex II Mitochondrial Respiratory Chain Deficiency, and treatment is supportive and symptomatic. Therapies may include nutritional management, physical therapy, and interventions to manage specific symptoms such as heart or breathing problems. In some cases, coenzyme Q10 supplements may be beneficial, although their efficacy varies.

Prognosis

The prognosis for individuals with Complex II Mitochondrial Respiratory Chain Deficiency depends on the severity of the disease and the organs affected. The condition can be life-threatening in severe cases, particularly when significant heart or neurological involvement is present.

Complex 2 mitochondrial respiratory chain deficiency Resources
Latest articles Most recent articles Ongoing trials	Wikipedia